Gland Pharma Pays ₹1.40 Lakh Penalty Imposed

has paid a combined penalty of ₹1.40 lakh to NSE and BSE in connection with a technical compliance breach under SEBI LODR regulations concerning the appointment of an independent director aged over 75 years. The company settled the full penalty amount suo motu, taking the step to ensure timely closure of the matter. The penalty relates to regulatory compliance requirements governing the appointment of independent directors and does not represent a material financial impact for the company. The development highlights the importance of adhering to prescribed corporate governance and listing regulations. Investors will continue to monitor regulatory disclosures and compliance-related developments at the pharmaceutical company as it maintains its governance and reporting obligations.